Evidence map›Paper›PMID 32269004›Full record

SynthesisSchizophrenia research2020

Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.

Lawrence H Yang, Bernalyn Ruiz, Amar D Mandavia, Margaux M Grivel, Liang Y Wong, Michael R Phillips, Matcheri S Keshavan, Huijun Li, Jeffrey A Lieberman, Ezra Susser and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in Schizophrenia research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Targeting Serotonin 5-HTCNS drugs · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lawrence H YangNew York University, School of Global Public Health, 715 Broadway, New York, NY 10003, United States; Columbia University, Department of Epidemiology, Mailman School of Public Health, 622 West 168th Street, New York, NY 10032, United States. Electronic address: Lawrence.yang@nyu.edu.
Bernalyn RuizUniversity of Massachusetts Boston, Department of Counseling and School Psychology, 100 Morrisey Blvd, Boston, MA 02125, United States.
Amar D MandaviaTeachers College, Columbia University, Department of Counseling and Clinical Psychology, 525 West 120th St, New York, NY 10027, United States.
Margaux M GrivelNew York University, School of Global Public Health, 715 Broadway, New York, NY 10003, United States.
Liang Y WongCity College, City University of New York, Department of Clinical Psychology, 160 Convent Ave., New York, NY 10031, United States.
Michael R PhillipsColumbia University, Department of Epidemiology, Mailman School of Public Health, 622 West 168th Street, New York, NY 10032, United States; Shanghai Jiao Tong University School of Medicine, Shanghai Mental Health Center, 3210 Humin Road, Shanghai 201108, China; New York State Psychiatric Institute, 1051 Riverside Dr., New York, NY 10032, United States.
Matcheri S KeshavanHarvard Medical School Department of Psychiatry at Beth Israel Deaconess Medical Center, Boston, MA, United States.
Huijun LiFlorida A&M University, Department of Psychology, 501 Orr Dr., 203 B Gore Education Complex (GEC), Tallahassee, FL 32307, United States.
Jeffrey A LiebermanColumbia University, Department of Psychiatry, 1051 Riverside Dr, New York, NY 10032, United States; New York State Psychiatric Institute, 1051 Riverside Dr., New York, NY 10032, United States.
Ezra SusserColumbia University, Department of Epidemiology, Mailman School of Public Health, 622 West 168th Street, New York, NY 10032, United States; New York State Psychiatric Institute, 1051 Riverside Dr., New York, NY 10032, United States.
Larry J SeidmanHarvard Medical School Department of Psychiatry at Beth Israel Deaconess Medical Center, Boston, MA, United States.
William S StoneHarvard Medical School Department of Psychiatry at Beth Israel Deaconess Medical Center, Boston, MA, United States.

Funding

A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for SchizophreniaU01MH121766 · NIMH · YALE UNIVERSITY · PI KRYSTAL, JOHN H. · 2019 to 2022
$11.8M
Characterizing Cognition across the Lifespan in untreated psychosis in ChinaR01MH108385 · NIMH · NEW YORK UNIVERSITY · PI KESHAVAN, MATCHERI S., PHILLIPS, MICHAEL ROBERT · 2015 to 2019
$4.0M
The Neurobiology of Violence in a Psychosis-Risk CohortR01MH113861 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI GIRGIS, RAGY RAMSIS · 2017 to 2021
$3.2M
NIMH NIH HHS R01 MH108385NIMH NIH HHS R01 MH113861NIMH NIH HHS U01 MH121766
6 · The paper itself

Abstract

backgroundComparing the course of antipsychotic-naïve psychosis in low- and middle-income countries (LMIC) may help to illuminate core pathophysiologies associated with this condition. Previous reviews-primarily from high-income countries (HIC)-identified cognitive deficits in antipsychotic-naïve, first-episode psychosis, but did not examine whether individuals with psychosis with longer duration of untreated psychosis (DUP > 5 years) were included, nor whether LMIC were broadly represented.

methodA comprehensive search of PUBMED from January 2002-August 2018 identified 36 studies that compared cognitive functioning in antipsychotic-naïve individuals with psychosis (IWP) and healthy controls, 20 from HIC and 16 from LMIC.

resultsA key gap was identified in that LMIC study samples were primarily shorter DUP (<5 years) and were primarily conducted in urban China. Most studies matched cases and controls for age and gender but only 9 (24%) had sufficient statistical power for cognitive comparisons. Compared with healthy controls, performance of antipsychotic-naïve IWP was significantly worse in 81.3% (230/283) of different tests of cognitive domains assessed (90.1% in LMIC [118/131] and 73.7% [112/152] in HIC).

conclusionsMost LMIC studies of cognition in antipsychotic-naïve IWP adopted standardized procedures and, like HIC studies, found broad-based impairments in cognitive functioning. However, these LMIC studies were often underpowered and primarily included samples typical of HIC: primarily male, young-adult, high-school educated IWP, in their first episode of illness with relatively short DUP (<5 years). To enhance understanding of the long-term natural course of cognitive impairments in untreated psychosis, future studies from LMIC should recruit community-dwelling IWP from rural areas where DUP may be longer.

Indexed as

Antipsychotic AgentsCognitive DysfunctionPsychotic DisordersSchizophreniaAdultChinaCognitionDeveloping CountriesHumansMaleAntipsychotic AgentsCognitionCountriesLow- and middle-incomeSchizophreniaUntreated

Identifiers

PMID32269004
PMCPMC8985208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.